| Literature DB >> 21157515 |
Cong-Jun Li1, Robert W Li, Theodore H Elsasser.
Abstract
Using global expression profiling and pathway analysis on α-tocopherol-induced gene perturbation in bovine cells, this study has generated comprehensive information on the physiological functions of α-tocopherol. The data confirmed α-tocopherol is a potent regulator of gene expression and α-tocopherol possesses novel transcriptional activities that affect essential biological processes. The genes identified fall within a broad range of functional categories and provide the molecular basis for its distinctive effects. Enrichment analyses of gene regulatory networks indicate α-tocopherol alter the canonical pathway of lipid metabolism and transcription factors SREBP1 and SREBP2, (Sterol regulatory element binding proteins), which mediate the regulatory functions of lipid metabolism. Transcription factors HNF4-α (Hepatocyte nuclear factor 4), c-Myc, SP1 (Sp1 transcription factor), ESR1 (estrogen receptor 1, nuclear), and androgen receptor, along with several others, were centered as the hubs of transcription regulation networks. The data also provided direct evidence that α-tocopherol is involved in maintaining immuno-homeostasis through targeting the C3 (Complement Component 3) gene.Entities:
Keywords: ESR1; bovine cells; gene regulation; lipid metabolism; α-tocopherol
Year: 2010 PMID: 21157515 PMCID: PMC3001320 DOI: 10.4137/GRSB.S6007
Source DB: PubMed Journal: Gene Regul Syst Bio ISSN: 1177-6250
Figure 1.Alpha-tocopherol induces inhabitation of cell proliferation in Madin-Darby bovine kidney (MDBK) epithelial cells. A1–A4) Histogram plot of flow cytometry analysis of MDBK cells sorted by their DNA content in cells treated with 0, 10, 20 and 40 μM alpha-tocopherol respectively. (S: S-phase-DNA or the synthesis phase of the cell cycle. Synthesis occurs in the S phase and chromosomes are duplicated) B) Quantized cell population. G1/G0: cells in G1/G0 cell cycle phases; S: cells in S cell cycle phase.
Figure 2.Western blotting of proteins. This figure is representative of two experiments. Equal amount of protein from different samples were separated by SDS PAGE 4 to 20% polyacrylamide gradient gels and was transferred to a membrane for Western blotting. The graphic represent quantitation from two Western blots.
Figure 3.The top 10 most significant pathways, based on the overrepresentation analysis (P < 0.05) induced by α-topopherol treatment.
Figure 4.GeneGO Pathway Maps. The top scored map (map with the lowest P-value) based on the enrichment distribution sorted by ‘Statistically significant Maps’ set with the lowest P-value and ordered by –log10 of the P-value of the hypergeometric distribution: Regulation of lipid metabolismregulation of lipid metabolism through LXR, NF-Y and SREBP pathway. Experimental data is linked to and visualized on the maps as thermometer-like figures. Up-ward thermometers have red color and indicate up-regulated signals and down-ward (blue) ones indicate down-regulated expression levels of the genes.
α-tocopheryl modulates biological networks generated using transcription regulation algorithm.
| HNF4-alpha | macromolecule metabolic process (66.7%; 5.187e-10), biopolymer metabolic process (65.0%; 1.209e-09), cellular macromolecule metabolic process (65.0%; 2.383e-09), cellular biopolymer metabolic process (64.2%; 2.510e-09), regulation of macromolecule metabolic process (45.5%; 2.126e-08) | 134 | 133 | 7.17E-265 |
| c-Myc | regulation of gene expression (52.2%; 6.050e-15), regulation of macromolecule metabolic process (55.7%; 2.406e-14), regulation of macromolecule biosynthetic process (50.4%; 1.164e-13), regulation of metabolic process (56.5%; 1.356e-13), regulation of transcription (47.0%; 6.305e-13) | 121 | 120 | 2.99E-238 |
| SP1 | positive regulation of transcription, DNA-dependent (22.6%; 1.014e-12), positive regulation of RNA metabolic process (22.6%; 1.160e-12), positive regulation of transcription (23.6%; 3.335e-12), positive regulation of gene expression (23.6%; 4.892e-12), positive regulation of transcription from RNA polymerase II promoter (19.8%; 6.495e-12) | 109 | 108 | 8.17E-214 |
| ESR1 (nuclear) | negative regulation of cellular process (42.1%; 7.653e-11), positive regulation of transcription (25.0%; 4.580e-10), positive regulation of gene expression (25.0%; 6.145e-10), negative regulation of biological process (42.1%; 6.848e-10), positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (25.0%; 2.455e-09) | 80 | 80 | 3.39E-159 |
| p53 | negative regulation of cellular process (48.5%; 6.970e-13), negative regulation of biological process (48.5%; 7.026e-12), regulation of developmental process (42.4%; 5.969e-11), positive regulation of cellular process (45.5%; 1.403e-10), positive regulation of transcription, DNA-dependent (25.8%; 2.406e-10) | 71 | 70 | 2.84E-137 |
| Androgen receptor | positive regulation of cellular process (48.5%; 1.745e-12), negative regulation of metabolic process (32.4%; 9.730e-12), negative regulation of cellular metabolic process (30.9%; 2.354e-11), positive regulation of biological process (48.5%; 2.739e-11), positive regulation of transcription, DNA-dependent (26.5%; 4.319e-11) | 71 | 70 | 2.84E-137 |
| E2F1 | regulation of metabolic process (69.4%; 8.766e-14), regulation of gene expression (62.9%; 1.042e-13), regulation of RNA metabolic process (58.1%; 2.208e-13), regulation of cellular process (91.9%; 4.013e-13), regulation of macromolecule metabolic process (66.1%; 4.112e-13) | 65 | 65 | 4.12E-129 |
| AP-1 | negative regulation of cellular process (50.8%; 3.143e-13), negative regulation of biological process (50.8%; 3.053e-12), negative regulation of transcription (27.9%; 8.447e-12), negative regulation of macromolecule biosynthetic process (29.5%; 1.464e-11), negative regulation of gene expression (27.9%; 1.829e-11) | 65 | 65 | 4.12E-129 |
| NF-kB | positive regulation of transcription, DNA-dependent (30.6%; 6.831e-13), positive regulation of RNA metabolic process (30.6%; 7.635e-13), positive regulation of transcription (32.3%; 8.750e-13), positive regulation of gene expression (32.3%; 1.209e-12), positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (32.3%; 5.569e-12) | 65 | 64 | 2.65E-125 |
| C/EBPbeta | positive regulation of transcription (33.3%; 4.329e-13), positive regulation of gene expression (33.3%; 5.990e-13), positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (33.3%; 2.780e-12), positive regulation of macromolecule metabolic process (36.7%; 3.061e-12), positive regulation of transcription, DNA-dependent (30.0%; 4.164e-12) | 64 | 63 | 2.60E-123 |
Figure 5.Representative biological network generated using the Analyze Networks Transcription regulation Algorithm. Up-regulated genes are marked with red circles and down-regulated genes are marked with blue circles. The network is centered with NF-κB and ESR1. All other transcription factors are shown in the left panel. All the symbols in the network are listed in Supplement Figure S1.
Figure 6.GeneGo process networks: representation of the most significant biological process networks induced by α-tocopherol, sorted by statistically significant Networks, ordered by –log10 of the P-value of the hypergeometric distribution.
Most relevant networks generated using Analyze Networks (AN) algorithm.
| 1 | Organ development (80.0%), system development (84.0%), anatomical structure development (84.0%) | 50 | 7 | 196 | 9.21e-06 |
| 2 | Cellular component movement (44.0%), anatomical structure morphogenesis (58.0%), regulation of cellular component organization (40.0%) | 50 | 14 | 128 | 1.40e-14 |
| 3 | Response to organic substance (56.2%), positive regulation of cellular process (70.8%), regulation of multicellular organismal process (58.3%) | 50 | 13 | 85 | 2.67e-13 |
| 4 | Cellular response to chemical stimulus (29.7%), positive regulation of biological process (56.8%), cAMP biosynthetic process (10.8%) | 50 | 19 | 57 | 2.15e-21 |
| 5 | Organ morphogenesis (56.5%), anatomical structure morphogenesis (63.0%), regulation of developmental process (54.3%) | 50 | 17 | 38 | 4.80e-19 |
The functional networks unique for up- or down-regulated by α-tocopherol.
| 1 | Actin cytoskeleton organization (36.7%), actin filament-based process (36.7%), cytoskeleton organization (40.8%) | 50 | 15 | 3.27E-23 |
| 2 | Translation (23.3%), RNA processing (25.6%), Ribonucleoprotein complex biogenesis (16.3%) | 50 | 29 | 1.66E-56 |
| 3 | Response to stress (45.8%), cellular response to stimulus (31.2%), immune system development (20.8%) | 51 | 13 | 2.32E-19 |
| 1 | Cellular component organization (87.5%), cellular component movement (54.2%), cell projection organization (50.0%) | 52 | 13 | 7.85E-13 |
| 2 | Organ development (80.0%), system development (82.0%), Organ morphogenesis (56.0%) | 50 | 8 | 1.18E-06 |
| 3 | Response to organic substance (54.2%), response to endogenous stimulus (41.7%), positive regulation of biological process (62.5%) | 50 | 16 | 3.00E-17 |
Figure 7.The representative network of the most relevant biological networks that is unique to up-regulated networks using the Analyze Networks Transcription regulation Algorithm. This is a variant of the shortest paths algorithm with relative enrichment and relative saturation of networks with canonical pathways. Key network objects include ESR1, C3, Erk1/2 (shown in blue rectangles). Large orange rectangle highlights the transcription factors.
Figure 8.The representative networks of the most relevant biological networks that are unique to down-regulated networks using the Analyze Networks Transcription regulation Algorithm. This is a variant of the shortest paths algorithm with relative enrichment and relative saturation of networks with canonical pathways. The figure shows three (green, purple and red) merged down-regulated networks.